TipRanks on MSN
MicroPort NeuroTech steps up competition in brain vascular devices with new embolic agent trial
MicroPort NeuroTech Limited ($HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, ...
Rashmi Bagga, MD, DNB; Preeti Verma, MD; Neelam Aggarwal, MD; Vanita Suri, MD; J R Bapuraj, MD; Naveen Kalra, MD Gonadotropin-releasing hormone agonists have been used as an adjunct to embolization ...
Good afternoon, and welcome to the TriSalus Life Sciences Virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the TriSalus ...
In an expert Q&A, Hospital for Special Surgery’s Lisa Mandl, MD, MPH, discusses the role of genicular nerve ablation in ...
Researchers detailed a rare case linking delayed hematoma to cyst formation years after stereotactic radiosurgery for ...
Think tank says China could see 100,000 casualties in Taiwan invasion attempt Neurovascular intervention devices are essential in treating various neurological conditions such as epilepsy, stroke, and ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results